Scabies Outbreak Prescribing Service (Scarborough)

Location

East Riding of Yorkshire

Description

Scabies outbreak prescribing service (Scarborough) by GP Practice which will include deployment of prescribing pharmacist to review treatment, medical records and prescribe or supply licensed treatment in accordance with UKHSA guidance for scabies outbreak management. The Provider will liaise with care home staff to ensure prescriptions are collected and instruction is provided on how to administer treatment and undertake follow up review of symptomatic patients.

Total Quantity or Scope

Scabies outbreak prescribing service (Scarborough) by GP Practice which will include deployment of prescribing pharmacist to review treatment, medical records and prescribe or supply licensed treatment in accordance with UKHSA guidance for scabies outbreak management. The Provider will liaise with care home staff to ensure prescriptions are collected and instruction is provided on how to administer treatment and undertake follow up review of symptomatic patients. NHS Humber and North Yorkshire ICB is providing notice of an urgent award under The Health Care Services (Provider Selection Regime) Regulations 2023. Approximate lifetime value of the contract is £704 Contract term - 28 November 2025 - 12 December 2025.

Award Detail

Award Criteria

CPV Codes

• 85121100 - General-practitioner services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) urgent award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

Other Information

The contract has been awarded under the urgent award provision of the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The contract was awarded under Regulation 14(2)(a) an award must be made urgently, and 14(2)(c) to ensure patient safety was not compromised. The contract award was approved by the Chief Operating Officer (Acting) and Deputy Director of Finance and Investment. No conflicts of interest have been declared in relation to the contract award.